These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8792005)

  • 21. 5-Fluorouracil plus leucovorin as adjuvant treatment of an experimental liver tumor in rats.
    Carlsson G; Gustavsson BG; Spears CP; Hafström LO
    Anticancer Res; 1990; 10(3):813-6. PubMed ID: 2369095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-2 in neoadjuvant therapy potentiates inhibitory activity of 5-fluorouracil and interferon in experimental liver metastases.
    Lee M; Pierce A; Mahaffey W; Specht S; Stemmler N; Katoh A
    Anticancer Drugs; 1994 Apr; 5(2):239-43. PubMed ID: 8049506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorouracil plus interferon + folinic acid in regional and systemic therapy in colorectal cancer.
    Preiss J
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):220-4. PubMed ID: 1557652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental chemoendocrine therapy of human breast carcinoma xenograft serially transplanted into nude mice].
    Watanabe O
    Nihon Geka Gakkai Zasshi; 1994 Apr; 95(4):263-70. PubMed ID: 7910941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
    Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
    Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
    Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
    Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon alpha and 5'-deoxy-5-fluorouridine in colon cancer: effects as single agents and in combination on growth of xenograft tumours.
    Laurent PL; Tevaearai HT; Eliason JF; Givel JC; Odartchenko N
    Eur J Cancer; 1994; 30A(12):1859-65. PubMed ID: 7880618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial.
    Pan DY; Qiao JG; Chen JW; Huo YC; Zhou YK; Shi HA
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):211-5. PubMed ID: 14599971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral 5-FU is a more effective antimetastatic agent than UFT.
    Wang J; Yang M; Yagi S; Hoffman RM
    Anticancer Res; 2004; 24(3a):1353-60. PubMed ID: 15274295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamoxifen enhances the cytotoxicity of conventional chemotherapy in esophageal adenocarcinoma cells.
    Due SL; Watson DI; Bastian I; Ding GQ; Sukocheva OA; Astill DS; Vat L; Hussey DJ
    Surg Oncol; 2016 Sep; 25(3):269-77. PubMed ID: 27566033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis.
    Lindner DJ; Borden EC
    Int J Cancer; 1997 May; 71(3):456-61. PubMed ID: 9139884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells.
    De Filippi R; Prete SP; Giuliani A; Silvi E; Yamaue H; Nieroda CA; Greiner JW; De Vecchis L; Bonmassar E
    Anticancer Res; 1994; 14(5A):1767-73. PubMed ID: 7847809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAC-101, a benzoic acid derivative, inhibits liver metastasis of human gastrointestinal cancer and prolongs the life-span.
    Murakami K; Wierzba K; Sano M; Shibata J; Yonekura K; Hashimoto A; Sato K; Yamada Y
    Clin Exp Metastasis; 1998 May; 16(4):323-31. PubMed ID: 9626811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon alpha-2a.
    Yee LK; Allegra CJ; Steinberg SM; Grem JL
    J Natl Cancer Inst; 1992 Dec; 84(23):1820-5. PubMed ID: 1433371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eradication of hepatic metastases of carcinoma H-59 by combination chemoimmunotherapy with liposomal muramyl tripeptide, 5-fluorouracil, and leucovorin.
    Asao T; Shibata HR; Batist G; Brodt P
    Cancer Res; 1992 Nov; 52(22):6254-7. PubMed ID: 1423270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
    Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM
    Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of p65 gene in experimental colon cancer under the influence of 5-fluorouracil given alone and in combination with hormonal modulation.
    Melen-Mucha G; Balcerczak E; Mucha S; Panczyk M; Lipa S; Mirowski M
    Neoplasma; 2004; 51(4):319-24. PubMed ID: 15254665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model.
    Long BJ; Jelovac D; Handratta V; Thiantanawat A; MacPherson N; Ragaz J; Goloubeva OG; Brodie AM
    J Natl Cancer Inst; 2004 Mar; 96(6):456-65. PubMed ID: 15026471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Fluorouracil-resistant colonic tumors are highly responsive to sodium butyrate/interleukin-2 bitherapy in rats.
    Cordel S; Heymann MF; Boisteau O; Oliver L; Le Pendu J; Grégoire M; Meflah K
    Int J Cancer; 1997 Dec; 73(6):924-8. PubMed ID: 9399677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.